RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
90 hedge funds and large institutions have $14.4M invested in GALENA BIOPHARMA INC COM in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
61% less capital invested
Capital invested by funds: $36.5M → $14.4M (-$22.1M)
Holders
90
Holding in Top 10
–
Calls
$3.93M
Puts
$825K
Top Buyers
| 1 | +$450K | |
| 2 | +$164K | |
| 3 | +$114K | |
| 4 |
Goldman Sachs
New York
|
+$90.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$77K |
Top Sellers
| 1 | -$148K | |
| 2 | -$97.5K | |
| 3 | -$64.2K | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$53.6K |
| 5 |
Morgan Stanley
New York
|
-$39.3K |